Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 1:05 p.m.

    📋 Agios Pharmaceuticals, Inc. (AGIO) - Clinical Trial Update

    Filing Date: 2022-07-12

    Accepted: 2022-07-12 16:14:57

    Event Type: Clinical Trial Update

    Event Details:

    Agios Pharmaceuticals Inc (AGIO) Announces Clinical Trial Update Agios Pharmaceuticals Inc (AGIO) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: leader, reflected
    • Clinical Stage: pivotal trial
    • Collaboration: Agios’ board of directors

    🔬 Clinical Development Pipeline (Agios Pharmaceuticals, Inc.):

    Product Type Development Stage Therapeutic Area Source
    Mitapivat-matching placebo OTHER Phase PHASE2 Sickle Cell Disease ClinicalTrials.gov
    Mitapivat DRUG Phase PHASE2 Sickle Cell Disease ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Agios Pharmaceuticals Inc
    • CIK: 0001439222
    • Ticker Symbol: AGIO
    • Period End Date: 2022-07-07
    • Document Type: 8-K

Search

News categories